Chris Fulmer is a technology and business lawyer who advises companies on the transactions and operational decisions that shape how they grow and operate. Known for a pragmatic, business-oriented approach, he brings more than 35 years of experience working with companies in the technology and pharmaceutical industries.

He represents a cross-section of North Carolina’s business community – from multinational pharmaceutical and technology companies to closely held, smaller businesses – and guides them through acquisitions, investments, and complex commercial arrangements. His work includes helping companies buy and sell assets ranging from individual product lines to entire businesses, negotiating licensing and distribution agreements, supporting investments, and structuring transactions tied to product development and commercialization.

Chris also advises clients on operational and regulatory matters that arise as businesses scale, including negotiating clinical trial agreements and ensuring compliance with evolving privacy and data protection laws in the United States and internationally.

Chris’s approach is informed by his in-house experience. Prior to joining Morningstar Law Group, he served as associate general counsel at a multinational contract research organization, where he negotiated hundreds of commercial agreements, supported investments in numerous early-stage companies, and played a key role in the company’s sale to two private equity firms.